相关实验视频
Updated: Jun 25, 2025

02:26
Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
5.2K
合成的阿波芬类化合物是对利氏综合征的潜在治疗方法
Mizuki Kobayashi1, Akihiko Miyauchi1, Eriko F Jimbo1
1Department of Pediatrics, Division of Pediatrics, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan.
Scientific reports
|May 21, 2024
概括
研究人员开发了新型的阿波莫芬衍生物来治疗线粒体疾病. 这些化合物表现出高细胞保护作用和抗费洛灭活性,而不会引起恶心,提供了一个有前途的治疗途径.
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 线粒体疾病源于呼吸链功能障碍,呈现出不同的遗传和表型变异.
- 目前对线粒体疾病的治疗方法有限,需要基本的治疗策略.
- 李氏综合征 (LS) 是一种严重的,进展性脑病变,与线粒体功能障碍有关.
研究的目的:
- 合成和评估新型阿波莫尔芬衍生物,用于线粒体疾病的潜在治疗应用.
- 识别具有显著抗细胞死亡和线粒体保护作用的化合物.
- 评估合成衍生物的多巴胺激动剂活性和潜在的排泄副作用.
主要方法:
- 从26种类似物中合成了20种阿波莫尔芬衍生物.
- 在患者衍生纤维细胞中对抗细胞死亡效应的评估.
- 评估多巴胺激动剂活性和线粒体功能.
- 确定抗费罗普托菌活性.
主要成果:
- 三种新型的阿波莫尔芬衍生物在11位具有活性基组,表现出强大的抗细胞死亡效应.
- 这些衍生品表现出显著的抗ferroptotic活性.
- 这些已识别的化合物具有针对线粒体疾病的高治疗潜力,没有吐性多巴胺激动剂活性.
结论:
- 新型合成阿波芬类化合物是线粒体疾病的有效治疗方法.
- 这些化合物可以克服与阿波莫尔芬相关的低生物可用性问题.
- 衍生品在治疗与铁亡相关的疾病方面表现有前途.
更多相关视频
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
279
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
279
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Analgesia and Pain Management
582
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
582
Opioid Analgesics: Morphine and Other Natural Cogeners
239
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
239
Opioid Receptors: Overview
739
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
739
Adrenergic Agonists: Indirect-Acting Agents
1.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.6K

